Investor FAQs

1.When was Adverum founded?
2.Where is Adverum headquartered?
3.On which exchange is Adverum listed, what is the ticker symbol, and when did it go public?
4.Who is Adverum's transfer agent?
5.If my address changes, whom should I notify?
6.When is Adverum's fiscal year-end?
7.Who are Adverum's legal counsel and independent auditors?
1.When was Adverum founded?
 Adverum was incorporated in Delaware in 2006.

2.Where is Adverum headquartered?
 Adverum's headquarters are located at:

Adverum Biotechnologies
1035 O’Brien Drive, Suite A
Menlo Park, CA 94025

The main telephone number is: (650) 272-6269.

3.On which exchange is Adverum listed, what is the ticker symbol, and when did it go public?
 Adverum's stock is traded on the NASDAQ Global Market under the symbol ADVM. The company’s initial public offering (IPO) was on July 31, 2014.

4.Who is Adverum's transfer agent?
 Adverum's transfer agent is:

Wells Fargo Shareowner Services
1110 Centre Pointe Curve, Suite 101
MAC N9173-010
Mendota Heights, MN 55120

The main telephone number is: (800) 689-8788.

5.If my address changes, whom should I notify?
 If your shares are held in your name, you must contact our transfer agent, Wells Fargo Shareowner Services. If your shares are held in street name, you must contact your broker to update your address.

6.When is Adverum's fiscal year-end?
 Adverum's fiscal year ends on December 31st.

7.Who are Adverum's legal counsel and independent auditors?
 Adverum's legal counsel is:

Munger Tolles & Olson LLP
355 South Grand Ave., 35th Floor
Los Angeles, CA 90071
Phone: (213) 683-9100

Adverum's independent auditor is:

Deloitte & Touche LLP
225 West Santa Clara Street
San Jose CA 95113-2303
Phone: (408) 704-4000